🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Gradual Versus Intermittent Release of Tourniquet Effect on MAP in Hypertensive Patients Undergoing Upper Limb Orthopedic Surgeries

RecruitingNAAges 18 Years - 65 YearsAllKasr El Aini Hospital
NCT07290504 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In this clinical trial, the authors will compare two tourniquet deflation techniques and their clinical implications on hemodynamics and acid base parameters in hypertensive orthopedic patients undergoing upper limb surgeries under general anesthesia.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Hypertensive patients (controlled on medical treatment more than three months) * Patients scheduled for upper limb orthopedic surgeries using a tourniquet for at least 30 min. * BMI from 18.5 to 29.9 Exclusion Criteria: * Patient refusal * ASA physical status \> II * Multiple orthopedic surgeries * Emergency surgeries * Patient with relative contraindications for tourniquet use
💊

What it tests

  • Tourniquet deflation
📍

Where

1 site
Cairo university hospitals
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy